Literature DB >> 17531548

Blunted ventilatory response to hypoxia/hypercapnia in mice with cigarette smoke-induced emphysema.

F Xu1, J Zhuang, R Wang, J C Seagrave, T H March.   

Abstract

It has been reported that the degree of emphysema induced by chronic cigarette smoke (CS) is greater in female C3H/HeN mice as compared to other mouse strains. We hypothesized that these mice would develop the similar major characteristics seen in hypercapnic patients with chronic obstructive pulmonary disease (COPD), including emphysema, pulmonary inflammation, hypercapnia/hypoxemia, rapid breathing, and attenuated ventilatory response (AVR). Mice were exposed either to CS or filtered air (FA) for 16 weeks. After exposure, arterial blood gases and minute ventilation were measured before and during chemical challenges in anesthetized and spontaneously breathing mice. We found that as compared to FA, CS exposure caused emphysema and pulmonary inflammation associated with: (1) hypercapnia and hypoxemia, (2) rapid breathing, and (3) AVR to 25 breaths of pure N(2), 5% CO(2) alone, and 5% CO(2) coupled with 10% O(2). The similarity of these pathophysiological characteristics between our mouse model and COPD patients suggests that this model could be effectively applied to study COPD pathophysiology, especially central mechanisms of the AVR genesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531548      PMCID: PMC2703296          DOI: 10.1016/j.resp.2007.04.004

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  44 in total

Review 1.  Chronic obstructive pulmonary disease * 3: Experimental animal models of pulmonary emphysema.

Authors:  R Mahadeva; S D Shapiro
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

2.  The effect of obstruction to breathing on the ventilatory response to CO2.

Authors:  R M CHERNIACK; D P SNIDAL
Journal:  J Clin Invest       Date:  1956-11       Impact factor: 14.808

3.  Lack of positive interaction between CO2 and hypoxic stimulation for P(CO2)-VAS response slope in humans.

Authors:  A Masuda; Y Ohyabu; T Kobayashi; C Yoshino; Y Sakakibara; T Komatsu; Y Honda
Journal:  Respir Physiol       Date:  2001-07

Review 4.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

5.  Effects of hypercapnia and inspiratory flow-resistive loading on respiratory activity in chronic airways obstruction.

Authors:  M D Altose; W C McCauley; S G Kelsen; N S Cherniack
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

6.  Control of breathing in patients with chronic obstructive lung disease.

Authors:  J Sorli; A Grassino; G Lorange; J Milic-Emili
Journal:  Clin Sci Mol Med       Date:  1978-03

Review 7.  Experimental studies on emphysema and chronic bronchial injury.

Authors:  G L Snider
Journal:  Eur J Respir Dis Suppl       Date:  1986

Review 8.  COPD exacerbations: the importance of a standard definition.

Authors:  R Pauwels; P Calverley; A S Buist; S Rennard; Y Fukuchi; E Stahl; C G Löfdahl
Journal:  Respir Med       Date:  2004-02       Impact factor: 3.415

9.  Sleep arterial oxygen desaturation and chemical control of breathing during wakefulness in COPD.

Authors:  K Tatsumi; H Kimura; F Kunitomo; T Kuriyama; S Watanabe; Y Honda
Journal:  Chest       Date:  1986-07       Impact factor: 9.410

Review 10.  Respiratory failure in chronic obstructive pulmonary disease.

Authors:  P M A Calverley
Journal:  Eur Respir J Suppl       Date:  2003-11
View more
  8 in total

1.  Role of CXCL5 in leukocyte recruitment to the lungs during secondhand smoke exposure.

Authors:  Gayathriy Balamayooran; Sanjay Batra; Shanshan Cai; Junjie Mei; G Scott Worthen; Arthur L Penn; Samithamby Jeyaseelan
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-23       Impact factor: 6.914

2.  Effect of Hypercapnia, an Element of Obstructive Respiratory Disorder, on Pancreatic Cancer Chemoresistance and Progression.

Authors:  Avinoam Nevler; Samantha Z Brown; David Nauheim; Carla Portocarrero; Ulrich Rodeck; Jonathan Bassig; Christopher W Schultz; Grace A McCarthy; Harish Lavu; Theresa P Yeo; Charles J Yeo; Jonathan R Brody
Journal:  J Am Coll Surg       Date:  2020-02-11       Impact factor: 6.113

3.  Hydrogen sulfide ameliorates tobacco smoke-induced oxidative stress and emphysema in mice.

Authors:  Weihong Han; Zheng Dong; Christiana Dimitropoulou; Yunchao Su
Journal:  Antioxid Redox Signal       Date:  2011-06-13       Impact factor: 8.401

4.  Inhalation of the nerve gas sarin impairs ventilatory responses to hypercapnia and hypoxia in rats.

Authors:  Jianguo Zhuang; Fadi Xu; Matthew J Campen; Cancan Zhang; Juan C Pena-Philippides; Mohan L Sopori
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-28       Impact factor: 4.219

5.  Metalloelastase in lungs and alveolar macrophages is modulated by extracellular substance P in mice.

Authors:  J Xu; F Xu; E Barrett
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-04-25       Impact factor: 5.464

6.  Hypoxia-induced ventilatory responses in conscious mice: gender differences in ventilatory roll-off and facilitation.

Authors:  Lisa A Palmer; Walter J May; Kimberly deRonde; Kathleen Brown-Steinke; Benjamin Gaston; Stephen J Lewis
Journal:  Respir Physiol Neurobiol       Date:  2012-11-24       Impact factor: 1.931

7.  Prenatal nicotinic exposure augments cardiorespiratory responses to activation of bronchopulmonary C-fibers.

Authors:  Jianguo Zhuang; Lei Zhao; Na Zang; Fadi Xu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-03-06       Impact factor: 6.011

8.  Depressed Hypoxic and Hypercapnic Ventilatory Responses at Early Stage of Lethal Avian Influenza A Virus Infection in Mice.

Authors:  Jianguo Zhuang; Peng Gao; Zemmie Pollock; Kevin S Harrod; Fadi Xu
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.